Consistent with these <i>in vitro</i> findings, ATG5 OE CAR-T cells exhibited enhanced antitumor efficacy <i>in vivo</i> under IR-preconditioned settings, characterized by improved tumor control and survival, which was associated with sustained effector function of tumor-infiltrating CAR-T cells. This evidence concerns the gene ATG5 and neoplasm.